Literature DB >> 33540662

Human Respiratory Syncytial Virus Infection in a Human T Cell Line Is Hampered at Multiple Steps.

Ricardo de Souza Cardoso1,2, Rosa Maria Mendes Viana1, Brenda Cristina Vitti1, Ana Carolina Lunardello Coelho1, Bruna Laís Santos de Jesus1, Juliano de Paula Souza1, Marjorie Cornejo Pontelli1, Tomoyuki Murakami2, Armando Morais Ventura3, Akira Ono2, Eurico Arruda1.   

Abstract

Human respiratory syncytial virus (HRSV) is the most frequent cause of severe respiratory disease in children. The main targets of HRSV infection are epithelial cells of the respiratory tract, and the great majority of the studies regarding HRSV infection are done in respiratory cells. Recently, the interest on respiratory virus infection of lymphoid cells has been growing, but details of the interaction of HRSV with lymphoid cells remain unknown. Therefore, this study was done to assess the relationship of HRSV with A3.01 cells, a human CD4+ T cell line. Using flow cytometry and fluorescent focus assay, we found that A3.01 cells are susceptible but virtually not permissive to HRSV infection. Dequenching experiments revealed that the fusion process of HRSV in A3.01 cells was nearly abolished in comparison to HEp-2 cells, an epithelial cell lineage. Quantification of viral RNA by RT-qPCR showed that the replication of HRSV in A3.01 cells was considerably reduced. Western blot and quantitative flow cytometry analyses demonstrated that the production of HRSV proteins in A3.01 was significantly lower than in HEp-2 cells. Additionally, using fluorescence in situ hybridization, we found that the inclusion body-associated granules (IBAGs) were almost absent in HRSV inclusion bodies in A3.01 cells. We also assessed the intracellular trafficking of HRSV proteins and found that HRSV proteins colocalized partially with the secretory pathway in A3.01 cells, but these HRSV proteins and viral filaments were present only scarcely at the plasma membrane. HRSV infection of A3.01 CD4+ T cells is virtually unproductive as compared to HEp-2 cells, as a result of defects at several steps of the viral cycle: Fusion, genome replication, formation of inclusion bodies, recruitment of cellular proteins, virus assembly, and budding.

Entities:  

Keywords:  HRSV R18 fusion assay; HRSV entry; HRSV filament formation; HRSV inclusion body-associated granules (IBAG′s); HRSV intracellular trafficking; HRSV low protein production; human respiratory syncytial virus (HRSV) infection in T-cell line; inefficient HRSV replication A3.01

Year:  2021        PMID: 33540662      PMCID: PMC7913106          DOI: 10.3390/v13020231

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  46 in total

1.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

Authors:  E A Kurt-Jones; L Popova; L Kwinn; L M Haynes; L P Jones; R A Tripp; E E Walsh; M W Freeman; D T Golenbock; L J Anderson; R W Finberg
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

2.  Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells.

Authors:  Homero San-Juan-Vergara; Viviana Sampayo-Escobar; Niradiz Reyes; Byeong Cha; Lisandro Pacheco-Lugo; Terianne Wong; Mark E Peeples; Peter L Collins; Maria Eugenia Castaño; Shyam S Mohapatra
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

3.  Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.

Authors:  K Anderson; E J Stott; G W Wertz
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

4.  Immunohistological demonstration of respiratory syncytial virus antigens in Paget disease of bone.

Authors:  B G Mills; F R Singer; L P Weiner; P A Holst
Journal:  Proc Natl Acad Sci U S A       Date:  1981-02       Impact factor: 11.205

5.  High rates of detection of respiratory viruses in tonsillar tissues from children with chronic adenotonsillar disease.

Authors:  Jose Luiz Proenca-Modena; Fabiana Cardoso Pereira Valera; Marcos Gerhardinger Jacob; Guilherme Pietrucci Buzatto; Tamara Honorato Saturno; Lucia Lopes; Jamila Mendonça Souza; Flavia Escremim Paula; Maria Lucia Silva; Lucas Rodrigues Carenzi; Edwin Tamashiro; Eurico Arruda; Wilma Terezinha Anselmo-Lima
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

6.  The steady state distribution of humTGN46 is not significantly altered in cells defective in clathrin-mediated endocytosis.

Authors:  G Banting; R Maile; E P Roquemore
Journal:  J Cell Sci       Date:  1998-12       Impact factor: 5.285

7.  A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles.

Authors:  Fyza Y Shaikh; Reagan G Cox; Aaron W Lifland; Anne L Hotard; John V Williams; Martin L Moore; Philip J Santangelo; James E Crowe
Journal:  MBio       Date:  2012-02-07       Impact factor: 7.867

8.  RSV glycoprotein and genomic RNA dynamics reveal filament assembly prior to the plasma membrane.

Authors:  Daryll Vanover; Daisy V Smith; Emmeline L Blanchard; Eric Alonas; Jonathan L Kirschman; Aaron W Lifland; Chiara Zurla; Philip J Santangelo
Journal:  Nat Commun       Date:  2017-09-22       Impact factor: 14.919

9.  Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein.

Authors:  Magdalena Anna Krzyzaniak; Michael Thomas Zumstein; Juan Atilio Gerez; Paola Picotti; Ari Helenius
Journal:  PLoS Pathog       Date:  2013-04-11       Impact factor: 6.823

Review 10.  Respiratory syncytial virus persistence in macrophages alters the profile of cellular gene expression.

Authors:  Evelyn Rivera-Toledo; Beatríz Gómez
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

View more
  1 in total

1.  Special Issue "Viral Infections in Developing Countries".

Authors:  Fabrício Souza Campos; Luciana Barros de Arruda; Flávio Guimaraes da Fonseca
Journal:  Viruses       Date:  2022-02-16       Impact factor: 5.048

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.